(46-HLT) Age-standardized five-year relative survival ratio for lung and bronchus cancer, (ICD-O-3 C34.0-C34.9) (November 2003 CCR file), by sex, 3 years of cases, Canada and selected provinces, 1992-1994

 Five-year  relative survival ratio for lung and bronchus cancer Relative survival ratio 95% confidence interval Number of cases Number of deaths
Low High
1992-1994  
Canada  
Both sexes 14 14 15 32,731 28,592
Males 13 13 14 20,694 18,377
Females 16 15 17 12,037 10,215
Newfoundland and Labrador  
Both sexes 16 13 19 550 468
Males 15 11 19 419 361
Females 18 11 25 131 107
Prince Edward Island  
Both sexes 11 7 16 238 216
Males F F F F F
Females 14 8 22 85 73
Nova Scotia  
Both sexes 13 12 15 1,657 1,464
Males 12 10 14 1,098 986
Females 16 13 19 559 478
New Brunswick  
Both sexes 14 12 16 1,368 1,204
Males 13 11 16 946 846
Females 16 13 20 422 358
Ontario  
Both sexes 15 15 16 17,349 15,054
Males 14 13 15 11,062 9,748
Females 17 16 18 6,287 5,306
Manitoba  
Both sexes 16 15 18 1,809 1,555
Males 15 13 17 1,138 997
Females 19 16 22 671 558
Saskatchewan  
Both sexes 12 10 14 1,433 1,283
Males 10 8 12 931 854
Females 16 12 19 502 429
Alberta  
Both sexes 13 11 14 3,073 2,716
Males 11 10 13 1,901 1,720
Females 15 13 17 1,172 996
British Columbia  
Both sexes 13 12 14 5,158 4,545
Males 13 11 14 2,989 2,669
Females 14 13 16 2,169 1,876
1. Data sources: Statistics Canada - Canadian Cancer Registry (CCR), National Cancer Incidence Reporting System, Canadian Vital Statistics (Death Database), and life tables
2. World Health Organization, International Classification of Diseases for Oncology, Third Edition (ICD-O-3).
3. Population-based survival estimates are based on the experience of a heterogeneous group of people and as such are useful "average" outcome indicators. They do not necessarily reflect a person's chances of surviving five years after diagnosis nor do the accompanying confidence intervals represent the range of possible prognoses for individual patients.
4. The results presented in this table reflect the survival experience of those diagnosed from 1992 to 1994 and followed up to 1999.
5. Observed survival is defined as the proportion of patients dying from any cause in a given time period.
6. Relative survival is defined as the ratio of the observed survival for a group of cancer patients to the survival that would have been expected for members of the general population, assumed to be practically free of the cancer of interest, who have the same main factors affecting patient survival (sex, age, place of residence) as the cancer patients. For example, women diagnosed with breast cancer in 1992 were, on average, 82% as likely to live for another five years as were women of the same age and in the same province at that time.
7. Analysis was conducted using the Ederer II method. Source: Ederer F, Heise H. The effect of eliminating deaths from cancer on general population survival rates, methodological note 11. National Cancer Institute, End Results Evaluation section, August 1959.
8. The analysis is restricted to cases that were the first primary cancer for the individual. The following cases are excluded: subjects with an unknown year of birth or death; subjects under 15 or over 99 years of age at diagnosis; subjects diagnosed through autopsy only or death certificate only.
9. The 95% confidence interval (CI) illustrates the degree of variability associated with an estimate. Wide confidence intervals indicate high variability, thus, these estimates should be interpreted with due caution. When estimates are based on a small number of cases, it is more likely that observed differences are due to random, rather than systematic influences.
10. Age-standardized survival estimates are interpretable as the overall survival estimate that would have occurred, if the age distribution of the patient group under study had been the same as that of the standard population. Unless they have been age-standardized to the same population, survival estimates from other sources should not be compared with those presented here.
11. Estimates were age-standardized using the direct method. Age-specific estimates for a given cancer were weighted to the age distribution of persons diagnosed with that cancer from 1992 to 2001 (Canadian Cancer Registry, November 21, 2003).
12. Only deaths within the first five years of follow-up are considered.
13. Some provincial/territorial cancer registries differ with respect to methods of data collection and registration of multiple primaries (more than one diagnosis of a primary cancer). There are also variations in the percentage of "death certificate only" (DCO) cases and the aggressiveness of follow-up, which varies by province or territory.
14. Age-standardized period (three years of cases) estimates were suppressed (F) for a given site/sex combination, if more than 40% of the age-specific groups for that combination had less than 10 cases or if any of the age-specific estimates used in their calculation were based on fewer than five cases.
15. Excluding morphology types M-9590-M-9989.
16. Québec data were not included because the method of ascertaining the date of diagnosis of cancer cases differs substantially from that of other provincial/territorial cancer registries.
17. Results for the territories are not shown because of an insufficient number of cases for analysis. Cases from these areas are, however, included in the national estimates.
18. The following standard symbols are used in Statistics Canada publications: (..) for figures not available for a specific reference period and (...) for figures not applicable.
19. CANSIM table number 01031530.